Top U.S. Health Officials/Epstein Becker & Green Attorneys to attend Biomed Israel 2008May 9, 2008
Representatives from the U.S. Department of Health and Human Services (DHHS), the Food and Drug Administration (FDA) and Leslie Norwalk, former U.S. Centers for Medicare and Medicaid Services (CMS) acting administrator and now EBG strategic counsel, will be moderated by Lynn Shapiro Snyder, senior EBG member and one of the leading U.S. lawyers helping biomedical, health care and life sciences companies commercialize their new products in the U.S.
Dr. Tevi Troy, DHHS deputy secretary and Dr. Daniel Schultz, FDA's Center for Devices and Radiological Health director, will join the panel.
Norwalk is also a member of EBG Advisors, Inc., a Washington, D.C. consultancy affiliated with the law firm Epstein Becker & Green.
Epstein Becker & Green has more than 125 attorneys dedicated to representing companies in the health care and life sciences industry, making this practice group one of the largest in health care and life sciences in the United States.
"I have heard much about the exciting innovation of Israeli biomedical, health care and life sciences companies," Norwalk said. "I also am looking forward to my first trip to Israel."
Ruti Alon, ILSI Biomed Israel 2008 co-chair, ILSI chairperson, and Pitango Venture Capital life sciences activities head, said: "I want Israeli companies to hear first-hand from senior U.S. health care policymakers about the challenges facing the U.S. health care market, such as quality and cost-containment, so that they can provide the solutions both for the U.S. and globally."
"It is very rare to get all three of these U.S. governmental perspectives on health care and life sciences issues on the same panel, let alone in Israel — a hot bed for innovation," Snyder noted. "The high caliber of participants on this panel and in all the other sessions is a testament to Israel's growing biomedical, health care and life sciences industries. EBG is excited to be a sponsor."
Snyder also will speak at a session on U.S. drug and device commercialization issues related to coding, coverage and payment, along with Robert Wanerman, EBG senior counsel, EBG Advisors member, and former DHHS attorney. According to Wanerman, "We have been helping Israeli and other foreign-based firms bring their new drugs, devices and biologics into the U.S. market, and I am looking forward to hearing about breakthroughs from the various companies showcasing at ILSI-Biomed 2008."
About ILSI-Biomed 2008 Convention
ILSI-Biomed 2008 (May 27-29, Tel Aviv) is expected to attract over 6,000 local and international CEOs, experts, academics, scientists, researchers, venture capitalists, and angel investors. This year, Israel's 60th anniversary, ILSI-Biomed will highlight 70 Israeli startups and exhibit medical innovations. The agenda covers industry trends, opportunities, challenges, regulatory and reimbursement issues, and therapies. The conference is also an excellent networking opportunity. The second International Stem Cell Meeting and ISRACAS 2008, the 11th Israel symposium on computer-aided surgery, medical robotics and medical imaging, will be held the same week.
About Epstein Becker & Green, P.C.
Founded in 1973, Epstein Becker & Green, P.C. is a law firm with nearly 400 lawyers practicing in offices in Atlanta, Chicago, Houston, Los Angeles, Miami, New York, Newark, San Francisco, Stamford and Washington D.C. The Firm's size, diversity, and global affiliations allow its attorneys to address the needs of both small entrepreneurial ventures and large multinational corporations on a worldwide basis.
EBG continues to build and expand its capabilities as a law firm focused on five core practices: Business Law, Health Care and Life Sciences, Labor and Employment, Litigation and Real Estate.
Josh Karlen, EBG Senior Public Relations Manager
(212) 351-3711 (direct) | JKarlen@ebglaw.com